KZIA - Kazia Therapeutics Limited

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Premium to download historical data

Income Statement

Currency in AUD. All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Breakdown
ttm
6/30/2019
6/30/2018
6/30/2017
6/30/2016
Total Revenue
-28.831
0
0
0
0
Operating Expense
9,662
8,822
12,487
10,354
12,771
Operating Income
-9,691
-8,822
-12,487
-10,354
-12,771
Net Non Operating Interest Income Expense
132.561
100
119
-516
406
Other Income Expense
-864.247
-1,848
6,023
1
210
Pretax Income
-10,421
-10,568
-6,344
-10,869
-12,155
Tax Provision
-298
-298
-305
-199
-
Net Income Common Stockholders
-10,123
-10,270
-6,039
-10,670
-12,062
Diluted NI Available to Com Stockholders
-10,123
-10,270
-6,039
-10,670
-12,062
Basic EPS
-
-0.0018
-0.0012
-0.0023
-0.0028
Diluted EPS
-
-0.0018
-0.0012
-0.0023
-0.0028
Basic Average Shares
-
5,750
4,838
4,678
4,274
Diluted Average Shares
-
5,750
4,838
4,678
4,274
Total Expenses
9,662
8,822
12,487
10,354
12,771
Net Income from Continuing & Discontinued Operation
-10,123
-10,270
-6,039
-10,670
-12,062
Normalized Income
-9,676
-8,511
-10,374
-10,654
-12,272
Interest Income
132.561
100
119
249
406
Interest Expense
-
-
-
765
0
Net Interest Income
132.561
100
119
-516
406
EBIT
-9,691
-8,822
-12,487
-10,104
-12,155
EBITDA
-8,607
-
-
-
-
Reconciled Depreciation
1,084
1,084
1,547
1,420
643
Net Income from Continuing Operation Net Minority Interest
-10,123
-10,270
-6,039
-10,670
-12,062
Total Unusual Items Excluding Goodwill
-460.66
-1,810
4,554
-16
210
Total Unusual Items
-460.66
-1,810
4,554
-16
210
Normalized EBITDA
-8,147
-5,928
-15,494
-8,668
-11,722
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-13.1731
-51.039
218.9423
-0.2929
0